Month: September 2024
-
J&J leader ready for new adventure
- 27 Sep 2024
In this week’s job moves, a senior leader departs J&J, two major patient orgs announce new CEOs, and a Novartis star continues to rise.
Read more -
Gilead hands out $130k in grants
- 27 Sep 2024
Expecting to donate $270,000 to organisations in blood and breast cancers and blood-borne viruses, the next funding round opens Oct 1.
Read more -
Astellas’ Tolstoshev is ready to serve
- 25 Sep 2024
Nirelle Tolstoshev is a busy person, and that is exactly how she likes it. She tells MedNews why she wants to also serve on the MA Board.
Read more -
Italian pharma joins MA as GM joins Board race
- 25 Sep 2024
Chiesi Australia is MA’s newest Class 1 member, its GM also a shock late starter for the Board election, but she’s no stranger to leadership.
Read more -
Jazz pulls back CBD unicorn from Chiesi in ANZ
- 25 Sep 2024
It is the only cannabinoid on the PBS and Chiesi’s third biggest earner, but now Jazz Pharma has built a neuro team and reclaimed Epidyolex.
Read more -
Gilead tops with ANZ patient groups
- 25 Sep 2024
64 patient groups rank ANZ pharma companies and while a big name pharma gets knocked off its perch, another jumps up to second place.
Read more -
Tori Brown does it her way
- 23 Sep 2024
She runs a marathon in a blistering pace and is doing the hard yards for Australian patients, this Lilly leader definitely no shrinking violet.
Read more -
Ex-GSK Australia boss takes RNAi shot
- 23 Sep 2024
Christi Kelsey was on an upward trajectory at GSK, but now she’s betting a new vaccine technology will change the future of health.
Read more






